Search for: "Matter of Roche"
Results 341 - 360
of 415
Sorted by Relevance
|
Sort by Date
25 May 2010, 5:00 pm
See Hoffmann-La Roche v. [read post]
20 Aug 2010, 6:27 am
Hoffmann-La Roche, Inc. v. [read post]
4 Nov 2010, 3:11 am
The Board thus concluded that the claimed subject matter does not meet the requirements of Art. 56 EPC and revoked the patent. [read post]
26 Feb 2010, 10:42 am
Hoffman-La Roche, Inc., 189 N.J. 615 (2007), the NJPLA "was intended 'to establish clear rules with respect to specific matters as to which the decisions of the courts in New Jersey have created uncertainty.'" Id. at 624 (quoting Senate Judiciary Committee, Statement to Senate Committee Substitute for S.B. [read post]
16 May 2013, 2:09 pm
Hoffman-La Roche, Inc., 771 F. [read post]
7 Apr 2023, 1:18 pm
Stringency can thus be non obvious, contested/contestable, and downside risk matters. [read post]
18 Jul 2013, 10:45 am
The main theory that the plaintiffs were able to come up with involved that last-refuge-of-a-scoundrel Restatement section, §324A “Good Samaritan” liability, that would have: (1) required publishers to investigate the substantive validity of everything they publish (the Philadelphia case involved clinical trials), and (2) would have placed anyone who published anything about a drug, no matter how limited, under a duty to research and publish everything. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
13 Jun 2008, 12:12 pm
Hoffmann-La Roche Inc., 891 A.2d 1229 (N.J. [read post]
16 Nov 2007, 4:00 am
., have called a truce in their worldwide patent war over GPS systems, settling all their litigation in the United States, United Kingdom and the Netherlands: (IPLaw360),AT&T's plan to placate Hollywood by adding antipiracy technology to its network: (IPLawDaily), Ocean Tomo announces results of auction held in late October: (PatentDocs), Technology Patents LLC has filed a lawsuit against 131 companies worldwide alleging infringement of patents relating to text messaging: (arstechnica),… [read post]
3 Apr 2012, 9:46 am
It is however an established principle of Strasbourg jurisprudence that such a right does not extend so far as to impose a positive obligation on public authorities to disclose or distribute information (see Leander v Sweden (1987) 9 EHRR 433 or Roche v United Kingdom (2005) 42 EHRR 599). [read post]
22 May 2024, 9:20 am
Core did not develop his invention “entirely on his own time” as a matter of law. [read post]
10 Oct 2009, 9:56 pm
”[13] According to Brazilian national law, one can bypass a patent if the holder is abusing his position as a monopolist.[14] The holder of the Nelfinavir patent, a Swiss pharmaceutical company named Roche, argued that they had conceded to give the Brazilian government a discount of 13% on the drug following extensive talks between the two parties.[15] The true fact of the matter was that Brazil spends over $300m per year on Nelfinavir alone because the country has the… [read post]
7 Oct 2011, 4:34 am
In the decisions from the last term, in fact, the Supreme Court agreed entirely with the Federal Circuit in Roche and Microsoft, a marked change from previous years. [read post]
14 Jun 2022, 6:30 am
I often quote what I call “Roche’s dictum,” which I heard John P. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the generic… [read post]
28 Mar 2008, 6:00 am
: (Patent Docs),US: Alnylam CEO forecasts ‘perfect storm’ for biomedical patents: (Patent Docs),US: Human Genome launches patent suit against Genentech over type of protein used to detect tumours: (IP Law360)Pharma & Biotech - ProductsCaduet (Atorvastatin/Amlodipine) – US: Pfizer sues Ranbaxy to block generic Caduet until 2016: (IP Law360),Dovonex (Calcipotriol) – Chancery Division EWHC grants interim injunction prohibiting Sandoz from distributing… [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars Technica),… [read post]
17 Dec 2011, 9:05 am
Specifically, the court in Caley did not address whether the right to proceed collectively under the FLSA may be waived as a matter of federal law. [read post]
